Daraxonrasib dose fractionation: opposing exposure metrics
Published daraxonrasib coefficients show opposing peak and minimum-concentration changes after fractionation, with conditional rather than validated safety projections.
I use Google Analytics to understand site visits. Allow optional analytics cookies? Privacy
I am a mathematical biologist and a bioinformatics researcher in the pharmaceutical industry. I received my Ph.D. in Life Science from Hokkaido University in March 2025.
I study biological dynamics using mathematical models and data analysis, with an interest in pharmacometrics and systems biology.
ORCIDGoogle ScholarLinkedInGitHub
Published daraxonrasib coefficients show opposing peak and minimum-concentration changes after fractionation, with conditional rather than validated safety projections.
Candidate prioritization, in-vitro activity, infection-site exposure and clinical outcomes are different claims in the Omnii-1 phage report.
A donor-level reanalysis of public normal intestinal organoid data compares mean, tissue-region and CEA-area regressions using held-out donor prediction at a fixed TCE concentration.